Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Mablink Bioscience S.A.S.

Mablink Bioscience is a French-based biopharmaceutical company which has developed PSARlink™, an innovative and patented hydrophilic drug-linker technology that brings dramatically improved pharmacological properties to antibody-drug conjugates. Mablink Bioscience develops its own pipeline of ADC targeting several cancers with high unmet medical needs. *


Period Start 2021-04-27 existent
Products Industry PSARlink™ drug-linkers
  Industry 2 antibody-drug conjugate (ADC)
Person Person Lafay, Jean-Guillaume (Mablink Bioscience 202104 CEO + Co-Founder)
Region Region Lyon
  Country France
  Street 69 rue de la République
  City 69002 Lyon
    Address record changed: 2021-05-05
Basic data Employees n. a.
    * Document for �About Section�: Mablink Bioscience S.A.S.. (4/27/21). "Press Release: Mablink Bioscience, the Next Generation ADC Company, Raises €4 Million from a Syndicate of Private Investors". Lyon.
Record changed: 2021-05-05


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Mablink Bioscience S.A.S.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC A October 650x80px

» top